Estimates of pandemic influenza vaccine effectiveness in europe, 2009-2010: Results of influenza monitoring vaccine effectiveness in Europe (I-MOVE) multicentre case-control study
Valenciano, M., Kissling, E., Cohen, J.-M., Oroszi, B., Barret, A.-S., Rizzo, C., Nunes, B., Pitigoi, D., Camara, A.L., Mosnier, A., Horvath, J.K., O'Donnell, J., Bella, A., Guiomar, R., Lupulescu, E., Savulescu, C., Ciancio, B.C., Kramarz, P., Moren, A.
First steps in the design of a system to monitor vaccine effectiveness during seasonal and pandemic influenza in EU/EEA Member States
Valenciano, M., Ciancio, B., Moren, A.
Influenza-related deaths - available methods for estimating numbers and detecting patterns for seasonal and pandemic influenza in Europe
Nicoll, A., Ciancio, B.C., Lopez Chavarrias, V., Mølbak, K., Pebody, R., Pedzinski, B., Penttinen, P., van der Se, M., Snacken, R., van Kerkhove, M.D.
Planning for uncertainty: A European approach to informing responses to the severity of influenza epidemics and pandemics
Use of oseltamivir in 12 European countries between 2002 and 2007 - lack of association with the appearance of oseltamivir-resistant influenza A(H1N1) viruses.
Kramarz, P., Monnet, D., Nicoll, A., Yilmaz, C., Ciancio, B.
Factsheet about seasonal influenza
Influenza is a contagious respiratory illness caused by influenza viruses that infect the nose, throat, and sometimes the lungs. It can cause mild to severe illness, and at times can lead to death. The best way to prevent flu is by getting a flu vaccine each year.
European Commission: Influenza
Vaccination policy is a competence of national authorities however, the European Commission supports EU countries to coordinate their policies and programmes. To support EU countries in maintaining or increasing rates of vaccination, the EU Commission promotes seasonal flu vaccination to at risk groups.
WHO Europe: Influenza
WHO/Europe aim to reduce influenza-related morbidity and mortality by strengthening virological and epidemiological surveillance for mild and severe influenza; using surveillance data to estimate the burden of influenza in order to prioritize national influenza vaccination programmes; and maintaining and strengthening pandemic preparedness activities at the national level. WHO/Europe also monitors the emergence of other respiratory pathogens that have the potential to spread among humans. These include coronaviruses, which cause a range of illnesses from severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome coronavirus (MERS-CoV) to the common cold.
Low uptake of seasonal influenza vaccination in Europe may jeopardise capacity to protect people in next pandemic
Influenza vaccination coverage among high-risk groups has dropped in the European Region over the last seven years, and half the countries report a decrease in the number of vaccine doses available.
Joint WHO/Europe–ECDC Annual European Influenza Surveillance Meeting, 2018
The joint annual influenza surveillance meeting by ECDC and the WHO Regional Office for Europe took place on 6 - 8 June 2018 in Copenhagen, Denmark. Invited participants were epidemiological and virological surveillance experts nominated by national health authorities as well as representatives from international institutions, covering the 53 countries of the EU/EEA and the WHO European region. The meeting was by invitation only.